He was one of the original scientists at Alexion as well as one of the original inventors of Soliris®. from Harvard Medical School in the Harvard-M.I.T. Joe is also a member of the Board of Directors of the YMCA of Greater Boston. Pfizer ha anunciado el nombramiento de Ana Maqueda como Directora de la planta biotecnológica de Pfizer en España, situada en la localidad madrileña de San Sebastián de los Reyes, en sustitución de David Breen, que se traslada a Estados Unidos para dirigir la planta biotecnológica de Kalamazoo, en Michigan (Estados Unidos). Los datos de carácter personal que nos proporciones en este formulario serán tratados por Barbizon SL como responsable de esta web. Earlier in her career, Kristin worked at Quintiles Strategic Research Services, Clinical Assistance Programs and Eastern Cooperative Oncology Group. Además de desarrollar su responsabilidad en la planta de San Sebastián de los Reyes, durante siete meses lideró la integración de la Planta de Zagreb (Croacia) después de su adquisición por Pfizer. La compañía biofarmacéutica Pfizer ha anunciado el nombramiento de Ana Maqueda como directora de su planta biotecnológica en España, situada en la localidad madrileña de San Sebastián de los Reyes, en sustitución de David Breen, que se traslada a Estados Unidos para dirigir la planta biotecnológica de Kalamazoo, en Michigan. Jeremy also served in a key strategic role as Alexion transitioned from a development-stage to a commercial-stage company. He completed his fellowship in hematology and oncology at Tufts-New England Medical Center and his Internal Medicine residency at the New England Deaconess Hospital in Boston. During his 13 years in investment banking, he advised on more than $20 billion in equity, debt and M&A transactions for leading biopharmaceutical companies. Nancy has overseen the successful development of numerous medicines. in Chemistry with Distinction from Purdue University, where he was an author on published papers and conducted research at the National Institutes of Health. In that role, Jeremy led the acquisitions of Enobia Pharma, Taligen Therapeutics and Orphatec, as well as the partnership with Moderna Therapeutics. David brings more than 20 years of experience in industry and academic clinical research with a strong track record of successful oncology and hematology drug development. Contact Details - find the Job Title, Phone#, Email Address, Social Profiles (Including Facebook, LinkedIn and Twitter) and the list of co-workers of David Murphy at Pfizer … Saturdays singer Una … Prior to 1992, Jeremy was a postdoctoral research fellow at the Brigham and Women's Hospital. in microbiology from the University Minnesota and a Ph.D. in microbiology and immunology from the University of Michigan. In addition to his extensive industry experience, David is an accomplished academic researcher and physician-scientist and was on the full-time faculty at Harvard Medical School and Beth Israel Deaconess Medical Center in the Division of Hematology/Oncology. Joe has significant financial, strategic and leadership experience in the biotechnology industry. In that role, she led more than 50 concurrent clinical studies across 15 programs and managed a functional team of more than 100 people across the United States, Europe and Asia. Prior to Syros, he was Executive Vice President and Chief Medical Officer of Infinity Pharmaceuticals and, previously, interim Co-head of Clinical Development and Vice President of Early Development in Pfizer’s Oncology Business Unit. Ana Maqueda, que es graduada en Ingeniería Mecánica por la Universidad Politécnica de Madrid (UPM), se unió a Pfizer en 1998, como jefa de Proyectos de Capital, y cuenta con una trayectoria con funciones de gran responsabilidad, ya que fue promocionada al Equipo de Liderazgo de la planta en 2010, cuando fue nombrada directora de Ingeniería y Mantenimiento, tal y como explica la entidad.